{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:08:40Z","timestamp":1761581320095},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T00:00:00Z","timestamp":1435104000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11255-015-1033-x","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T12:00:44Z","timestamp":1435060844000},"page":"1335-1341","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Risk stratification model, including preoperative serum C-reactive protein and estimated glomerular filtration rate levels, in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy"],"prefix":"10.1007","volume":"47","author":[{"given":"Shuichi","family":"Morizane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Yumioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriya","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Masago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Sejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,24]]},"reference":[{"issue":"7","key":"1033_CR1","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/cncr.24147","volume":"115","author":"KA David","year":"2009","unstructured":"David KA, Mallin K, Milowsky MI, Ritchey J, Carroll PR, Nanus DM (2009) Surveillance of urothelial carcinoma: stage and grade migration, 1993\u20132005 and survival trends, 1993\u20132000. Cancer 115(7):1435\u20131447. doi: 10.1002\/cncr.24147","journal-title":"Cancer"},{"issue":"4","key":"1033_CR2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eururo.2009.11.035","volume":"57","author":"R Zigeuner","year":"2010","unstructured":"Zigeuner R, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Weizer A, Kikuchi E, Remzi M, Raman JD, Bolenz C, Bensalah K, Capitanio U, Koppie TM, Kassouf W, Sircar K, Patard JJ, Fernandez MI, Wood CG, Montorsi F, Strobel P, Wheat JC, Haitel A, Oya M, Guo CC, Ng C, Chade DC, Sagalowsky A, Langner C (2010) Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 57(4):575\u2013581. doi: 10.1016\/j.eururo.2009.11.035","journal-title":"Eur Urol"},{"issue":"4","key":"1033_CR3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0090-4295(98)00295-7","volume":"52","author":"MC Hall","year":"1998","unstructured":"Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG (1998) Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52(4):594\u2013601","journal-title":"Urology"},{"issue":"4","key":"1033_CR4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.eururo.2010.07.003","volume":"58","author":"RL Favaretto","year":"2010","unstructured":"Favaretto RL, Shariat SF, Chade DC, Godoy G, Adamy A, Kaag M, Bochner BH, Coleman J, Dalbagni G (2010) The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 58(4):574\u2013580. doi: 10.1016\/j.eururo.2010.07.003","journal-title":"Eur Urol"},{"issue":"4","key":"1033_CR5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00345-011-0645-8","volume":"29","author":"W Otto","year":"2011","unstructured":"Otto W, Shariat SF, Fritsche HM, Gupta A, Matsumoto K, Kassouf W, Martignoni G, Walton TJ, Tritschler S, Baba S, Bastian PJ, Martinez-Salamanca JI, Seitz C, Pycha A, Burger M, Karakiewicz PI, Ficarra V, Novara G (2011) Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients. World J Urol 29(4):487\u2013494. doi: 10.1007\/s00345-011-0645-8","journal-title":"World J Urol"},{"issue":"4","key":"1033_CR6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.urology.2007.06.1106","volume":"70","author":"KS Cho","year":"2007","unstructured":"Cho KS, Hong SJ, Cho NH, Choi YD (2007) Grade of hydronephrosis and tumor diameter as preoperative prognostic factors in ureteral transitional cell carcinoma. Urology 70(4):662\u2013666. doi: 10.1016\/j.urology.2007.06.1106","journal-title":"Urology"},{"key":"1033_CR7","author":"M Rink","year":"2012","unstructured":"Rink M, Robinson BD, Green DA, Cha EK, Hansen J, Comploj E, Margulis V, Raman JD, Ng CK, Remzi M, Bensalah K, Kabbani W, Haitel A, Rioux-Leclercq N, Guo CC, Chun FK, Kikuchi E, Kassouf W, Sircar K, Sun M, Sonpavde G, Lotan Y, Pycha A, Karakiewicz PI, Scherr DS, Shariat SF (2012) Impact of Histological Variants on Clinical Outcomes of Patients with Upper Urinary Tract Urothelial Carcinoma. J Urol. doi: 10.1016\/j.juro.2012.04.009","journal-title":"J Urol"},{"issue":"6","key":"1033_CR8","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.eururo.2009.12.029","volume":"57","author":"G Novara","year":"2010","unstructured":"Novara G, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Bastian PJ, Martinez-Salamanca JI, Seitz C, Lemberger RJ, Burger M, El-Hakim A, Baba S, Martignoni G, Gupta A, Karakiewicz PI, Ficarra V, Shariat SF (2010) Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol 57(6):1064\u20131071. doi: 10.1016\/j.eururo.2009.12.029","journal-title":"Eur Urol"},{"issue":"2","key":"1033_CR9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.juro.2009.04.026","volume":"182","author":"WM Li","year":"2009","unstructured":"Li WM, Li CC, Ke HL, Wu WJ, Huang CN, Huang CH (2009) The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy. J Urol 182(2):451\u2013458. doi: 10.1016\/j.juro.2009.04.026 (discussion 458)","journal-title":"J Urol"},{"issue":"2","key":"1033_CR10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1464-410X.2007.06934.x","volume":"100","author":"K Saito","year":"2007","unstructured":"Saito K, Kawakami S, Ohtsuka Y, Fujii Y, Masuda H, Kumagai J, Kobayashi T, Kageyama Y, Kihara K (2007) The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. BJU Int 100(2):269\u2013273. doi: 10.1111\/j.1464-410X.2007.06934.x","journal-title":"BJU Int"},{"issue":"8","key":"1033_CR11","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1464-410X.2011.10479.x","volume":"109","author":"JI Martinez-Salamanca","year":"2012","unstructured":"Martinez-Salamanca JI, Shariat SF, Rodriguez JC, Chromecki TF, Ficarra V, Fritsche HM, Kassouf W, Matsumoto K, Cabello LO, Seitz C, Tritschler S, Walton TJ, Zattoni F, Novara G (2012) Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study. BJU Int 109(8):1155\u20131161. doi: 10.1111\/j.1464-410X.2011.10479.x","journal-title":"BJU Int"},{"issue":"1","key":"1033_CR12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/1097-0142(19940701)74:1<123::AID-CNCR2820740121>3.0.CO;2-T","volume":"74","author":"L Sengelov","year":"1994","unstructured":"Sengelov L, Kamby C, Schou G, von der Maase H (1994) Prognostic factors and significance of chemotherapy in patients with recurrent or metastatic transitional cell cancer of the urinary tract. Cancer 74(1):123\u2013133","journal-title":"Cancer"},{"issue":"1","key":"1033_CR13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11255-012-0347-1","volume":"45","author":"S Morizane","year":"2013","unstructured":"Morizane S, Iwamoto H, Masago T, Yao A, Isoyama T, Sejima T, Takenaka A (2013) Preoperative prognostic factors after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma. Int Urol Nephrol 45(1):99\u2013106. doi: 10.1007\/s11255-012-0347-1","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"1033_CR14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1442-2042.2010.02671.x","volume":"18","author":"T Suyama","year":"2011","unstructured":"Suyama T, Nakajima K, Kanbe S, Tanaka N, Hara H, Ishii N (2011) Prognostic significance of preoperative serum CYFRA 21-1 in patients with upper urinary tract urothelial carcinoma. Int J Urol 18(1):43\u201347. doi: 10.1111\/j.1442-2042.2010.02671.x","journal-title":"Int J Urol"},{"key":"1033_CR15","volume-title":"General rule for clinical and pathological studies on renal pelvic, ureteral and bladder cancer","author":"The Japanese Urological Association TJSoP, Japan Radiological Society","year":"2011","unstructured":"The Japanese Urological Association TJSoP, Japan Radiological Society (2011) General rule for clinical and pathological studies on renal pelvic, ureteral and bladder cancer, 1st edn. Kanehara & Co., Ltd., Tokyo","edition":"1"},{"issue":"8","key":"1033_CR16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jjco\/28.8.497","volume":"28","author":"M Kuroda","year":"1998","unstructured":"Kuroda M, Kotake T, Akaza H, Hinotsu S, Kakizoe T (1998) Efficacy of dose-intensified MEC (methotrexate, epirubicin and cisplatin) chemotherapy for advanced urothelial carcinoma: a prospective randomized trial comparing MEC and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin). Japanese Urothelial Cancer Research Group. Jpn J Clin Oncol 28(8):497\u2013501","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"1033_CR17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10147-011-0284-5","volume":"17","author":"T Inamoto","year":"2012","unstructured":"Inamoto T, Komura K, Watsuji T, Azuma H (2012) Specific body mass index cut-off value in relation to survival of patients with upper urinary tract urothelial carcinomas. Int J Clin Oncol 17(3):256\u2013262. doi: 10.1007\/s10147-011-0284-5","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"1033_CR18","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.eururo.2012.01.021","volume":"61","author":"EK Cha","year":"2012","unstructured":"Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martinez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V (2012) Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol 61(4):818\u2013825. doi: 10.1016\/j.eururo.2012.01.021","journal-title":"Eur Urol"},{"issue":"5","key":"1033_CR19","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.juro.2012.10.057","volume":"189","author":"M Roupret","year":"2013","unstructured":"Roupret M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, Fajkovic H, Lotan Y, Raman JD, Zigeuner R, Remzi M, Bolenz C, Novara G, Kassouf W, Ouzzane A, Rozet F, Cussenot O, Martinez-Salamanca JI, Fritsche HM, Walton TJ, Wood CG, Bensalah K, Karakiewicz PI, Montorsi F, Margulis V, Shariat SF, French National Databaseon Upper Tract T, Upper Tract Urothelial Carcinoma C (2013) Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. J Urol 189(5):1662\u20131669. doi: 10.1016\/j.juro.2012.10.057","journal-title":"J Urol"},{"issue":"6","key":"1033_CR20","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/bjc.2012.64","volume":"106","author":"DR Yates","year":"2012","unstructured":"Yates DR, Hupertan V, Colin P, Ouzzane A, Descazeaud A, Long JA, Pignot G, Crouzet S, Rozet F, Neuzillet Y, Soulie M, Bodin T, Valeri A, Cussenot O, Roupret M, French collaborative national database on U-U (2012) Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram. Br J Cancer 106(6):1083\u20131088. doi: 10.1038\/bjc.2012.64","journal-title":"Br J Cancer"},{"issue":"5","key":"1033_CR21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.eururo.2005.07.005","volume":"48","author":"G Fromont","year":"2005","unstructured":"Fromont G, Roupret M, Amira N, Sibony M, Vallancien G, Validire P, Cussenot O (2005) Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma. Eur Urol 48(5):764\u2013770. doi: 10.1016\/j.eururo.2005.07.005","journal-title":"Eur Urol"},{"issue":"5","key":"1033_CR22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1464-410X.2008.07659.x","volume":"102","author":"S Eltz","year":"2008","unstructured":"Eltz S, Comperat E, Cussenot O, Roupret M (2008) Molecular and histological markers in urothelial carcinomas of the upper urinary tract. BJU Int 102(5):532\u2013535. doi: 10.1111\/j.1464-410X.2008.07659.x","journal-title":"BJU Int"},{"issue":"7","key":"1033_CR23","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1442-2042.2006.01429.x","volume":"13","author":"PC Huang","year":"2006","unstructured":"Huang PC, Huang CY, Huang SW, Lai MK, Yu HJ, Chen J, Pu YS (2006) High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan. Int J Urol 13(7):864\u2013869. doi: 10.1111\/j.1442-2042.2006.01429.x","journal-title":"Int J Urol"},{"issue":"1","key":"1033_CR24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.ju.0000146713.50673.e5","volume":"173","author":"A Casamassima","year":"2005","unstructured":"Casamassima A, Picciariello M, Quaranta M, Berardino R, Ranieri C, Paradiso A, Lorusso V, Guida M (2005) C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy. J Urol 173(1):52\u201355. doi: 10.1097\/01.ju.0000146713.50673.e5","journal-title":"J Urol"},{"issue":"8","key":"1033_CR25","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1464-410X.2007.07408.x","volume":"101","author":"S Yoshida","year":"2008","unstructured":"Yoshida S, Saito K, Koga F, Yokoyama M, Kageyama Y, Masuda H, Kobayashi T, Kawakami S, Kihara K (2008) C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy. BJU Int 101(8):978\u2013981. doi: 10.1111\/j.1464-410X.2007.07408.x","journal-title":"BJU Int"},{"issue":"1","key":"1033_CR26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10549-008-9985-5","volume":"114","author":"BL Pierce","year":"2009","unstructured":"Pierce BL, Neuhouser ML, Wener MH, Bernstein L, Baumgartner RN, Ballard-Barbash R, Gilliland FD, Baumgartner KB, Sorensen B, McTiernan A, Ulrich CM (2009) Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat 114(1):155\u2013167. doi: 10.1007\/s10549-008-9985-5","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1033_CR27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/bjs.4038","volume":"90","author":"DC McMillan","year":"2003","unstructured":"McMillan DC, Canna K, McArdle CS (2003) Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 90(2):215\u2013219. doi: 10.1002\/bjs.4038","journal-title":"Br J Surg"},{"issue":"33","key":"1033_CR28","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1200\/JCO.2006.07.1381","volume":"24","author":"C Siemes","year":"2006","unstructured":"Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, Uitterlinden AG, Hofman A, Pols HA, Stricker BH (2006) C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 24(33):5216\u20135222. doi: 10.1200\/JCO.2006.07.1381","journal-title":"J Clin Oncol"},{"issue":"11","key":"1033_CR29","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1245\/s10434-012-2453-9","volume":"19","author":"P Colin","year":"2012","unstructured":"Colin P, Ouzzane A, Yates DR, Francois A, Pignot G, Arvin-Berod A, Merigot de Treigny O, Laurent G, Valeri A, Jacques I, Saint F, Gardic S, Gres P, Rozet F, Neuzillet Y, Ruffion A, Roupret M (2012) Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival. Ann Surg Oncol 19(11):3613\u20133620. doi: 10.1245\/s10434-012-2453-9","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"1033_CR30","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.28655","volume":"120","author":"S Porten","year":"2014","unstructured":"Porten S, Siefker-Radtke AO, Xiao L, Margulis V, Kamat AM, Wood CG, Jonasch E, Dinney CP, Matin SF (2014) Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma. Cancer 120(12):1794\u20131799","journal-title":"Cancer"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-1033-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-015-1033-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-015-1033-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T12:02:03Z","timestamp":1559390523000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-015-1033-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,24]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["1033"],"URL":"https:\/\/doi.org\/10.1007\/s11255-015-1033-x","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,24]]}}}